Clinical trial
Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as…
NCT00213031 · Population Council, Other · Completed
Key facts
| NCT number | NCT00213031 |
|---|---|
| Title | Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide |
| Official title | A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide |
| Lead sponsor | Population Council, Other |
| Collaborators | Bill and Melinda Gates Foundation Centers for Disease Control and Prevention U.S. Fed Nat'l Cntr. for HIV, STD, & TB Prevention Atlanta: Division of STD Prevention,Div. of HIV/AIDS… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Chlamydia Trachomatis, Neisseria Gonorrhoeae, Trichomonas Vaginitis, Syphilis, Herpes Simplex |
| Intervention type | Drug |
| Interventions | Carraguard (PC-515) |
| Enrollment | 165 |
| Start date | Feb 1, 2000 |
| Completion | Dec 1, 2001 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 14, 2017 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: